Stockreport

BriaCell Therapeutics Announces Closing of US$30 million Public Offering

BriaCell Therapeutics Corp. - Common Shares  (BCTX) 
PDF PHILADELPHIA and VANCOUVER, British Columbia, Jan. 15, 2026 (GLOBE NEWSWIRE) -- BriaCell Therapeutics Corp. (Nasdaq: BCTX, BCTXL) (TSX: BCT) (“BriaCell” or the “Compan [Read more]